140 related articles for article (PubMed ID: 27189050)
1. Isolated limb perfusion in Merkel cell carcinoma offers high rate of complete response and durable local-regional control: Systematic review and institutional experience.
Thiels CA; Gonzalez AB; Gray RJ; Jakub JW
J Surg Oncol; 2016 Aug; 114(2):187-92. PubMed ID: 27189050
[TBL] [Abstract][Full Text] [Related]
2. Long-term response of isolated limb perfusion with hyperthermia and chemotherapy for Merkel cell carcinoma.
Duprat JP; Domingues AL; Coelho EG; Leal RM; Nishinari K; Neves RI
Eur J Surg Oncol; 2009 Jun; 35(6):568-72. PubMed ID: 19013049
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study.
Olieman AF; Liénard D; Eggermont AM; Kroon BB; Lejeune FJ; Hoekstra HJ; Koops HS
Arch Surg; 1999 Mar; 134(3):303-7. PubMed ID: 10088573
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience.
van Veenendaal LM; Madu MF; Tesselaar MET; Verhoef C; Grünhagen DJ; van Akkooi ACJ
Eur J Surg Oncol; 2017 Nov; 43(11):2157-2162. PubMed ID: 28802661
[TBL] [Abstract][Full Text] [Related]
5. A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
Chai CY; Deneve JL; Beasley GM; Marzban SS; Chen YA; Rawal B; Grobmyer SR; Hochwald SN; Tyler DS; Zager JS
Ann Surg Oncol; 2012 May; 19(5):1637-43. PubMed ID: 22143576
[TBL] [Abstract][Full Text] [Related]
6. Improved durable responses regardless of age following cytoreduction and "no-tourniquet" hyperthermic isolated limb chemotherapy for in transit melanoma of the extremity.
Wang T; Osborne N; Rechtenwald J; Kim A; Matusko N; Mayle R; Cohen MS
Am J Surg; 2019 Dec; 218(6):1114-1121. PubMed ID: 31630826
[TBL] [Abstract][Full Text] [Related]
7. In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients.
Zeitouni NC; Giordano CN; Kane JM
Dermatol Surg; 2011 Mar; 37(3):357-64. PubMed ID: 21324044
[TBL] [Abstract][Full Text] [Related]
8. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
Knorr C; Meyer T; Janssen T; Goehl J; Hohenberger W
Eur J Surg Oncol; 2006 Mar; 32(2):224-7. PubMed ID: 16289716
[TBL] [Abstract][Full Text] [Related]
10. Results of isolated limb perfusion for metastasized malignant melanoma.
Schellerer VS; Frenger J; Merkel S; Goehl J; Kersting S; Gruetzmann R; Erdmann M; Foertsch T
Surg Oncol; 2021 Sep; 38():101603. PubMed ID: 33992896
[TBL] [Abstract][Full Text] [Related]
11. [Regional chemotherapy--perfusion of the extremities].
Meyer T; Göhl J
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():200-4. PubMed ID: 11824246
[TBL] [Abstract][Full Text] [Related]
12. Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.
Sharma K; Beasley G; Turley R; Raymond AK; Broadwater G; Peterson B; Mosca P; Tyler D
Ann Surg Oncol; 2012 Aug; 19(8):2563-71. PubMed ID: 22476748
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma: report of 10 cases and review of the literature.
Akhtar S; Oza KK; Wright J
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Boesch CE; Meyer T; Waschke L; Merkel S; Goehl J; Hohenberger W; Knorr C
Int J Hyperthermia; 2010 Feb; 26(1):16-20. PubMed ID: 20100048
[TBL] [Abstract][Full Text] [Related]
15. [Continued complete remission of Merkel cell carcinoma with in-transit metastasis after treatment with isolated limb perfusion regional chemotherapy].
Grandpeix C; Bonvalot S; Petrow P; Fraitag S; Gounod N; Avril MF
Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):700-3. PubMed ID: 17053743
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: an unusual indication for isolated limb perfusion.
Ponte P; Moniz JV; Farricha V; Weinholtz JB
Dermatol Online J; 2008 Jul; 14(7):6. PubMed ID: 18718190
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of in-transit metastases from Merkel's cell carcinoma with isolated hyperthermic limb perfusion.
Gupta AS; Heinzman S; Levine EA
South Med J; 1998 Mar; 91(3):289-92. PubMed ID: 9521375
[TBL] [Abstract][Full Text] [Related]
18. Predicting disease progression after regional therapy for in-transit melanoma.
Lidsky ME; Turley RS; Beasley GM; Sharma K; Tyler DS
JAMA Surg; 2013 Jun; 148(6):493-8. PubMed ID: 23558401
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment.
Hoekstra HJ; Schraffordt Koops H; de Vries LG; van Weerden TW; Oldhoff J
Cancer; 1993 Aug; 72(4):1224-9. PubMed ID: 8393368
[TBL] [Abstract][Full Text] [Related]
20. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
